14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Price (Quote)

New York Stock Exchange
Open Broker Account
$0.130
+0 (+0%)
At Close: Jan 16, 2018
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 MSTX stock ended at $0.130. During the day the stock fluctuated 0% from a day low at $0.130 to a day high of $0.130.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Mast Therapeutics, Inc prices

Date Open High Low Close Volume
Feb 16, 2017 $0.130 $0.132 $0.125 $0.129 5 256 160
Feb 15, 2017 $0.140 $0.140 $0.130 $0.130 6 778 751
Feb 14, 2017 $0.140 $0.142 $0.135 $0.135 4 278 289
Feb 13, 2017 $0.152 $0.158 $0.116 $0.142 11 164 955
Feb 10, 2017 $0.142 $0.148 $0.132 $0.146 9 158 472
Feb 09, 2017 $0.140 $0.142 $0.133 $0.135 3 414 612
Feb 08, 2017 $0.138 $0.139 $0.133 $0.139 3 880 933
Feb 07, 2017 $0.142 $0.142 $0.134 $0.137 3 731 527
Feb 06, 2017 $0.170 $0.170 $0.131 $0.139 6 403 358
Feb 03, 2017 $0.133 $0.136 $0.128 $0.133 5 732 192
Feb 02, 2017 $0.133 $0.133 $0.128 $0.128 3 078 482
Feb 01, 2017 $0.130 $0.130 $0.130 $0.130 2 397 439
Jan 31, 2017 $0.134 $0.135 $0.127 $0.132 5 539 587
Jan 30, 2017 $0.138 $0.140 $0.130 $0.132 4 439 357
Jan 27, 2017 $0.145 $0.147 $0.134 $0.138 6 030 966
Jan 26, 2017 $0.140 $0.150 $0.140 $0.143 7 204 296
Jan 25, 2017 $0.130 $0.149 $0.127 $0.139 11 798 128
Jan 24, 2017 $0.135 $0.135 $0.128 $0.129 3 267 848
Jan 23, 2017 $0.130 $0.134 $0.128 $0.131 3 171 927
Jan 20, 2017 $0.130 $0.140 $0.120 $0.130 4 537 996
Jan 19, 2017 $0.130 $0.136 $0.125 $0.130 7 035 252
Jan 18, 2017 $0.139 $0.143 $0.135 $0.140 6 321 000
Jan 17, 2017 $0.150 $0.150 $0.133 $0.140 7 123 428
Jan 13, 2017 $0.142 $0.143 $0.132 $0.140 8 247 917
Jan 12, 2017 $0.148 $0.152 $0.140 $0.140 7 044 813
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Golden Star

Ticker Date Change Price
BBCA May 03 1.26% $65.44
ADTH May 03 5.56% $3.24
ISTB May 03 0.0425% $47.11
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
INVH May 03 1.72% $34.39
INTU May 03 1.89% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT